Sarepta Shares Soar After FDA Reverses Pause For …
Shares of Sarepta Therapeutics erupted in premarket trading after the Food and Drug Administration…
Tag: Sarepta
Sarepta Plunges Again After Europe Rejects Elevidys
Perhaps analysts at HC Wainwright & Co. were right about their 12-month zero-dollar price target…
FDA Asks Sarepta To Halt Gene Therapy After Three…
Sarepta Therapeutics is in hot water with the FDA and its stock has been hammered after three deaths…
“Painful Decision”: Sarepta Suspends All…
Just hours after Children's Hospital Los Angeles halted the use of Sarepta Therapeutics'…
Sarepta Price Target Slashed To $0 At H.C. Wainwright…
Shares of Sarepta dropped as much as 11% in premarket trading and remain down about 6% after the…
Sarepta Refuses FDA Request to Halt Elevidys After…
Sarepta Therapeutics Inc. has refused a request from the U.S. Food and Drug Administration to halt…
Sarepta Shares Crash 25% After Third Patient Death…
Sarepta Therapeutics has confirmed a third patient death linked to its gene therapy programs, this…
TRENDING
